Related Experiment Videos
Treatment of haemophilia in the developing countries
1Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. raajs@mahidol.ac.th
Insights
Haemophilia care in developing countries requires integrated healthcare systems, early diagnosis, and accessible treatments. Continuous research and education are vital for improving outcomes for children with haemophilia.
Area of Science:
- Hematology
- Public Health
- Pediatrics
Background:
- Haemophilia predominantly affects children in developing nations due to insufficient treatment, leading to limited lifespans.
- Haemophilia often lacks priority in healthcare systems facing numerous other serious health challenges.
Purpose of the Study:
- To outline a comprehensive strategy for improving haemophilia care in developing countries.
- To emphasize the need for integrated healthcare, education, and research.
Main Methods:
- Proposing integration of haemophilia care into primary, treatment, comprehensive, and reference centers.
- Recommending early diagnosis from the antenatal stage, confirmed by lab testing.
- Suggesting local production of qualified therapeutics alongside affordable imported factor concentrates.
Main Results:
- Local production of fibrin glue can support dental procedures without blood components.
- Home care treatment is feasible, even for parents with limited literacy.
- Education of medical and healthcare personnel through curricula is crucial.
Conclusions:
- An integrated, multi-tiered healthcare approach is essential for haemophilia management.
- Accessible diagnostics, therapeutics, and home care empower patients and families.
- Sustained research is critical for advancing haemophilia care in resource-limited settings.
Abstract:
In developing countries, most of the patients with haemophilia are in the paediatric age group as they seldom reach adulthood because of inadequate treatment. Haemophilia is not given the priority it deserves as there are high numbers of other serious health problem. Haemophilia care should be integrated into the existing healthcare system of a primary care centre, a treatment centre, a comprehensive care centre and a reference centre. It is considered important to educate the personnel through the curriculum of medical students and all healthcare personnel. Diagnosis should be started at the antenatal stage and subsequently confirmed by laboratory testings. Qualified therapeutic products should be produced locally in combination with imported affordable factor concentrate. In-house preparation of fibrin glue is helpful for dental procedures without the need for any blood component. Home care treatment is essential and can be adopted even by parents with low literacy. Lastly, research for laboratory diagnosis, treatment and prevention should be continuously conducted to serve people with haemophilia specifically in developing countries.